Early Real-Life Experience with Spesolimab in the Treatment of Generalized Pustular Psoriasis: A Case Series of Three Patients Treated in a Compassionate Use Program
These real-world observations support the clinical efficacy of spesolimab for managing acute GPP flares and demonstrate its potential as a therapeutic option in severe cases, even before commercial access.
Authors
- Lars Iversen (ORCID: https://orcid.org/0000-0003-1816-4508)
- Trine Bertelsen (ORCID: https://orcid.org/0000-0002-4777-1991)
- Anne Hald Rittig (ORCID: https://orcid.org/0000-0001-7983-8671)
- Sascha Dinsen Wreschner Stave (ORCID: https://orcid.org/0009-0009-0586-9489)
Institutions
- Bispebjerg Hospital (DK)
- Aarhus University Hospital (DK)
- MC2 Therapeutics (Denmark) (DK)
Publication Details
- Journal
- Case Reports in Dermatology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1159/000547428
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00